Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Glioma × Minocycline × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

cyclopia sequence 1 Lung Neoplasms 1 Glioma 1 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Temozolomide 24 Radiotherapy 10 Bevacizumab 10 Carboplatin 6 pembrolizumab 4 Radiation 4 Nivolumab 4 Irinotecan 4 IL13-PE38 4 Surgical Procedures, Operative 3 Erlotinib Hydrochloride 3 Aminolevulinic Acid 3 trametinib 2 temsirolimus 2 fludarabine 2 dabrafenib 2 abemaciclib 2 Vorinostat 2 Radiotherapy, Intensity-Modulated 2 Radiosurgery 2 Magnetic Resonance Spectroscopy 2 Immunotherapy, Adoptive 2 Imatinib Mesylate 2 Cyclophosphamide 2 Chlorotoxin 2 Cetuximab 2 Cancer Vaccines 2 Biopsy 2 vocimagene amiretrorepvec 1 veliparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01580969 2019-08-16

RAMBO

University of Utah

Phase 1/2 Completed

22 enrolled 18 charts

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡